ECM
STLN

Element Capital Management’s Starling Oncology STLN Stock Holding History

Element Capital Management’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-599,800
Closed -$5.97M – 76
2021
Q1 		$5.97M Sell
599,800
-250,200
-29% -$2.67M 1.37% 24
2020
Q4 		$9.18M Buy
+850,000
New +$8.75M 0.96% 20

Other funds holding STLN

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Element Capital Management's STLN Position: Q2 2021 in Review

Element Capital Management sold out of Starling Oncology (STLN) in Q2 2021, closing a stake of 599,800 shares — an estimated $5.97M sold.

Element Capital Management first reported a position in STLN in Q4 2020 and held it in 2 quarters. The position peaked at $9.18M in Q4 2020. 53 funds tracked by Wall St. Rank hold STLN as of Q2 2021.

  • Element Capital Management reported no remaining Starling Oncology position as of Q2 2021 after selling out during the quarter.
  • Element Capital Management sold 599,800 Starling Oncology shares in Q2 2021, an estimated $5.97M.
  • Element Capital Management first reported a position in Starling Oncology in Q4 2020 and held it in 2 quarters.
  • Element Capital Management's Starling Oncology position peaked at $9.18M in Q4 2020.
  • 53 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2021.

Based on Element Capital Management's 13F filing for Q2 2021, filed 11 Aug 2021.